METABOLIC STRATEGIES OF LATENT MYCOBACTERIUM TUBERCULOSIS
METABOLIC STRATEGIES OF LATENT MYCOBACTERIUM TUBERCULOSIS
批准号:
6099099
负责人:
Clifton Barry
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Asymptomatic mycobacterial infections are
characterized by the presence of very few bacilli which are difficult
to find, may not be acid-fast, and may not be culturable. These
bacilli have been proposed to persist within closed airways of the
mammalian lung under what have been described as microaerophilic
or anaerobic conditions. We have begun characterizing the
biochemical changes which accompany the adaptation to
microaerophilic survival and replication. We have shown that the
mycobacterial a-crystallin protein is specifically expressed during
stationary-phase and under low-oxygen conditions in virulent
mycobacterial strains. This protein was overexpressed and purified
and shown to have ATP-independent chaperone function and to
provide protection from autolysis to aging bacteria. Targeted gene
replacement was used to create a genetic knockout of the alpha
crystallin protein in virulent MTB and the resulting strain shows
dramatically decreased abilities in growth and replication in
macrophage models of infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
-
批准号:8555979
-
项目类别:
-
资助金额:$57.3万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Development Of New Chemotherapeutics For Tuberculosis
-
批准号:9161485
-
项目类别:
-
资助金额:$75.65万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Exploring the metabolism of non-replicating and drug-resistant TB
-
批准号:8745359
-
项目类别:
-
资助金额:$59.91万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
-
批准号:8946454
-
项目类别:
-
资助金额:$60.8万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Experimental Animal Models of TB: Chemotherapeutics and Imaging
-
批准号:9354740
-
项目类别:
-
资助金额:$130.7万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
-
批准号:8336279
-
项目类别:
-
资助金额:$78.43万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Development Of New Chemotherapeutics For Tuberculosis
-
批准号:7732501
-
项目类别:
-
资助金额:$128.85万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Experimental Animal Models of TB: Chemotherapeutics and Imaging
-
批准号:10692048
-
项目类别:
-
资助金额:$153.83万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
The Molecular Target of Isoniazid in Pathogenic Mycobacteria
-
批准号:6099057
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Development Of New Chemotherapeutics For Tuberculosis
-
批准号:7592197
-
项目类别:
-
资助金额:$681.13万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Exploring the metabolism of non-replicating and drug-resistant TB
-
批准号:8555825
-
项目类别:
-
资助金额:$65.51万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Development Of New Chemotherapeutics For Tuberculosis
-
批准号:10692040
-
项目类别:
-
资助金额:$153.83万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
-
批准号:7732715
-
项目类别:
-
资助金额:$115.38万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Experimental Animal Models of TB: Chemotherapeutics and Imaging
-
批准号:10014061
-
项目类别:
-
资助金额:$144.41万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
CAP: Development of a Tuberculosis-Specific PET Imaging Agent
-
批准号:8556067
-
项目类别:
-
资助金额:$26.82万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Experimental Animal Models of TB: Chemotherapeutics and Imaging
-
批准号:10272059
-
项目类别:
-
资助金额:$146.95万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
CAP: Development of a Tuberculosis-Specific PET Imaging Agent
-
批准号:8946528
-
项目类别:
-
资助金额:$19.38万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
BIOSYNTHETIC MODIFICATIONS OF MYCOLIC ACIDS IN MYCOBACTERIUM TUBERCULOSIS
-
批准号:6099026
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Development Of New Chemotherapeutics For Tuberculosis
-
批准号:8555802
-
项目类别:
-
资助金额:$63.58万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
Experimental Animal Models of TB: Chemotherapeutics and Imaging
-
批准号:8555814
-
项目类别:
-
资助金额:$63.58万
-
财政年份:--
-
负责人:Clifton Barry
-
依托单位:
海外基金